Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Treatment; Moussa B.H. Youdim

Moussa B H Youdim1

  • 1Youdim Pharmaceutical, New Northern Industrial Park, 1 Ha- Tsmika St. Stern Building, Fl-3, Yokneam, Israel. moussa.youdim@youdim.com.

Journal of Neural Transmission (Vienna, Austria : 1996)
|April 8, 2022
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A sporadic Parkinson's disease model via silencing of the ubiquitin-proteasome/E3 ligase component, SKP1A.

Journal of neural transmission (Vienna, Austria : 1996)·2023
Same author

Lewy bodies, iron, inflammation and neuromelanin: pathological aspects underlying Parkinson's disease.

Journal of neural transmission (Vienna, Austria : 1996)·2023
Same author

The Neuroprotective Activities of the Novel Multi-Target Iron-Chelators in Models of Alzheimer's Disease, Amyotrophic Lateral Sclerosis and Aging.

Cells·2023
Same author

Correction to: Lithium's Gene Expression Profile, Relevance to Neuroprotection A cDNA Microarray Study.

Cellular and molecular neurobiology·2022
Same author

Site-activated multi target iron chelators with acetylcholinesterase (AChE) and monoamine oxidase (MAO) inhibitory activities for Alzheimer's disease therapy.

Journal of neural transmission (Vienna, Austria : 1996)·2022
Same author

The protective, rescue and therapeutic potential of multi-target iron-chelators for retinitis pigmentosa.

Free radical biology & medicine·2021